Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMO | O15229 | 1/20 | 0.35 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.34 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.34 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.34 |
| ▸ | ERN1 | O75460 | 8/20 | 0.33 |
| ▸ | DHFR | P00374 | 1/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | CNR1 | P21554 | 1/20 | 0.31 |
| ▸ | CNR2 | P34972 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22693493 | 0.78 | ASH1L (0.34) | CNR1CNR2 | |
| SCHEMBL22248190 | 0.76 | L3MBTL1 (0.43) | KMOPRSS1PRSS2PRSS3MAPT | |
| SCHEMBL22186194 | 0.74 | KMO (0.41) | KMOPRSS1PRSS2PRSS3HDAC8 | |
| SCHEMBL21668856 | 0.74 | TNKS2 (0.44) | — | |
| SCHEMBL20243663 | 0.73 | PRSS1 (0.46) | KMOPRSS1PRSS2PRSS3DHFR | |
| SCHEMBL18789928 | 0.72 | MAPT (0.47) | MAPTLMNAGAA | |
| SCHEMBL19802271 | 0.72 | L3MBTL1 (0.54) | MAPTLMNAGAA | |
| SCHEMBL1073773 | 0.71 | AKT1 (0.50) | MAPTTDP1LMNA | |
| SCHEMBL1073772 | 0.71 | AKT1 (0.50) | MAPTTDP1LMNA | |
| SCHEMBL14780997 | 0.71 | AKT1 (0.50) | MAPTTDP1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230322691-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2023-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230322691-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | CCNT1, CCNE2, SCO2 | KMO 1204/4885PRSS1 4458/4885PRSS2 3992/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.